Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377–8.PubMedCrossRef
Agras WS. Understanding compliance with the medical regimen: the scope of the problem and a theoretical perspective. Arthritis Care Res. 1989;2(suppl):S2-S7.PubMedCrossRef
Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DL (eds). Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979;1–7.
Steiner JF, Fihn SD, Blair B, Inui TS. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol. 1991;44:1361–71.PubMedCrossRef
Sackett DL. A compliance practicum for the busy practitioner. In: Haynes RB, Taylor DW, Sackett DL (eds). Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979;121.
Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner’s Guidebook. New York: Plenum Press, 1987;21, 44–5.
Haynes RB, Dantes R. Patient compliance and the conduct and interpretation of therapeutic trials. Controlled Clin Trials. 1987;8:12–9.PubMedCrossRef
Goldsmith CH. The effect of compliance distributions on therapeutic trials. In: Haynes RB, Taylor DW, Sackett DL (eds). Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979;297–308.
Lang JM, Buring JE, Rosner B, Cook N, Hennekens CH. Estimating the effect of the run-in on the power of the Physicians’ Health Study. Stat Med. 1991;10:1585–93.PubMed
Maenpaa H, Manninen V, Heinonen OP. Compliance with medication in the Helsinki Heart Study. Eur J Clin Pharmacol. 1992;42:15–9.PubMedCrossRef
Maenpaa H, Manninen V, Heinonen OP. Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial. Eur Heart J. 1987;8:39–43.PubMed
Caron HS. Compliance: the case for objective measurement. J Hypertens. 1985;3(suppl 1):11–7.
Gordon ME, Kass MA. Validity of standard compliance measures in glaucoma compared with an electronic eyedrop monitor. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;163–73.
Fletcher W, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting. Arch Intern Med. 1979;139:635–8.PubMedCrossRef
Sackett DL, Haynes RB, Guyatt G, Tugwell P. Clinical Epidemiology, 2nd ed. Boston: Little, Brown, 1991;258–61.
Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting tablets? Clin Pharmacol Ther. 1989;46:163–8.PubMedCrossRef
Rudd P, Ahmed S, Zachary V, Barton C, Bondoelle D. Improved compliance measures: applications in an ambulatory hypertensive trial. Clin Pharmacol Ther. 1990;48:676–85.PubMedCrossRef
Haynes RB, Gibson ES, Hackett BC, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;I:1265–8.CrossRef
Spilker B. Methods of assessing and improving patient compliance in clinical trials. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;37–56.
Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509–10.PubMedCrossRef
Johnson CE, Carlin SA, Super DM, et al. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr. 1991;119:117–22.PubMedCrossRef
Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;3–10.
Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? JAMA. 1989;261:3273–7.PubMedCrossRef
Cheung R, Sullen CM, Seal D, et al. The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community. Br J Clin Pharmacol. 1988;26:391–8.PubMed
Spector SL, Mawhinny H. Aerosol inhaler monitoring of asthmatic medication. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;149–62.
Kruse W, Weber E. Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 1990;38:561–5.PubMedCrossRef
Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E. Compliance with short-term high-dose ethinyl oestradiol in young patients with primary infertility. New insights from the use of electronic devices. In: AAS 29: Risk Factors for Adverse Drug Actions. Basel: Birkhauser Verlag, 1990;105–15.
Olivieri NF, Matsui D, Hermann C, Koren G. Compliance assessed by the medication event monitoring system. Arch Dis Child. 1991;66:1399–402.PubMed
Eisen SA, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med. 1987;2:298–305.PubMedCrossRef
Rudd P, Ahmed S, Zachary V, Barton C, Bondelle D. Compliance with medication timing: implications from a medication trial for drug development and clinical practice. J Clin Res Pharmaco-epidemiol. 1992;6:15–27.
Probstfield JL. Clinical trial prerandomization compliance (adherence) screen. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;323–33.
Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med. 1979;30l:1410–2.CrossRef
Katz R. Regulatory view: use of subgroup data for determination of efficacy. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;251–63.
Feinstein A. Intent-to-treat policy for analyzing randomized trials: statistical distortions and neglected clinical challenges. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;359–70.
Hasford J. Biometric issues in measuring and analyzing partial compliance in clinical trials. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;265–81.
Lasagna L, Hutt PB. Health care, research, and regulatory impact of noncompliance. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;393–403.
Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365–74.CrossRef
Cohen SJ (ed). New Directions in Patient Compliance. Lexington, MA: Lexington Books, 1979.
Sackett DL, Haynes RB (eds). Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins University Press, 1976.
Peck CL, King NJ. Increasing patient compliance with prescriptions. JAMA. 1982;248:2874–7.PubMedCrossRef
Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100:258–68.PubMed
Fletcher RH. Patient compliance with therapeutic advice: a modern view. Mt Sinai J Med (NY). 1989;56:453–8.
Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther. 1988;44:540–5.PubMedCrossRef
Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881–4.PubMedCrossRef
Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;121:664–9.PubMedCrossRef
Rudd P. Medication packaging: simple solutions to non-adherence problems. Clin Pharmacol Ther. 1979;25:257–65.PubMed
Lima J, Nazarian L, Charney E, Lahti C. Compliance with short-term antimicrobial therapy: some techniques that help. Pediatrics. 1976;57:383–6.PubMed
Morris LA, Halperin JA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health. 1979;69:47–52.PubMed
Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92:495–502.PubMedCrossRef
McKenney JM, Munroe WP, Wright JT Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol. 1992;32:277–83.PubMed
Norell SE. Improving medication compliance: a randomized clinical trial. BMJ. 1979;2:1031–3.PubMed
Sackett DL, Haynes RB, Gibson ES, et al. Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205–7.PubMedCrossRef
Inui TS, Yourtee EL, Williamson JW. Improved outcomes in hypertension after physician tutorials: a controlled trial. Ann Intern Med. 1976;84:646–51.PubMed
Epstein LH. The direct effects of compliance on health outcome. Health Psychol. 1984;3:385–93.PubMedCrossRef
Efron B, Feldman D. Compliance as an explanatory variable in clinical trials. J Am Stat Assoc. 1991;86:9–26.CrossRef
Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987;317:1237–45.PubMedCrossRef
Horowitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990;336:542–5.CrossRef
Dorus W, Ostrow DG, Anton R, et al. Lithium treatment of depressed and nondepressed alcoholics. JAMA. 1989;262:1646–52.PubMedCrossRef
Urquhart J. Patient compliance as an explanatory variable in four selected cardiovascular studies. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;301–22.
Packer M. The placebo effect in heart failure. Am Heart J. 1990;120:1579–82.PubMedCrossRef
Lavin MR. Placebo effects on mind and body. JAMA. 1991;265:1753–4.PubMedCrossRef
Kessner DM. Infant death, an analysis by maternal risk and health care. In: Contrasts in Health Status, Vol. 1. Washington, DC: National Academy of Science, 1973.
Roth HP, Caron HS, Hsi BP. Estimating a patient’s cooperation with his regimen. Am J Med Sci. 1971;262:269–73.PubMedCrossRef
Davis KL, Estess FM, Simonton SC, et al. Effects of payment mode on clinic attendance and rehospitalization. Am J Psychol. 1977;134:576–8.
Orlinsky N, D’Elia E. Rehospitalization of the schizophrenic patient. Arch Gen Psychiatry. 1964;10:71–8.
Bigby JA, Pappius E, Cook EF, Goldman L. Medical consequences of missed appointments. Arch Intern Med. 1984;144:1163–6.PubMedCrossRef
Gortmaker SL. The effects of prenatal care on the health of the newborn. Am J Public Health. 1979;69:653–60.PubMed
Leveno KJ, Cunningham FG, Roark ML, et al. Prenatal care and the low birth weight infant. Obstet Gynecol. 1985;66:599–605.PubMed
Goldman L, Freidin R, Cook EF, Eigner J, Grich P. A multivariate approach to the prediction of no-show behavior in a primary care center. Arch Intern Med. 1982;142:563–7.PubMedCrossRef
Gates SJ, Colborn DK. Lowering appointment failures in a neighborhood health center. Med Care. 1976;14:263–7.PubMedCrossRef
Greenlick MR, Freeborn DK, Colombo TJ, et al. Comparing the use of medical care services by a medically indigent and a general membership population in a comprehensive prepaid group practice program. Med Care. 1972;10:187–200.PubMedCrossRef
Fiester AR, Rudestam KE. A multivariate analysis of the early dropout process. J Consult Clin Psychol. 1975;43:528–35.PubMedCrossRef
Deyo RA, Inui TS. Dropouts and broken appointments-a literature review and agenda for future research. Med Care. 1980;18:1146–57.PubMedCrossRef
Gruzd DC, Shear CL, Rodney WM. Determinants of no-show appointment behavior: the utility of multivariate analysis. Fam Med. 1986;18:217–20.PubMed
Frankel S, Farrow A, West R. Non-attendance or non-invitation? A case-control study of failed outpatient appointments. BMJ. 1989;298:1343–5.PubMedCrossRef
Dove HG, Schneider KC. The usefulness of patients’ individual characteristics in predicting no-shows in outpatient clinics. Med Care. 1981;19:734–40.PubMedCrossRef
Steinwachs DM. Measuring provider continuity in ambulatory care: as assessment of alternative approaches. Med Care. 1979;551–65.
Hermoni D, Mankuta D, Reis S. Failure to keep appointments at a community health centre-analysis of causes. Scand J Prim Healthcare. 1990;8:151–5.
Whitcher-Alagna S. Receiving medical help: a psychosocial perspective on patient reactions. In: Nadler A, Fisher JD, DePaulo BM. New Directions in Helping. New York: Academic Press, 1983.
Dunbar JM, Agras WS. Compliance with medical instructions. In: Ferguson JM, Taylor CB (eds). Comprehensive Handbook of Behavioral Medicine. New York: Spectrum, 1980.
Benjamin-Bauman J, Reiss ML, Bailey JS. Increasing appointment keeping by reducing the call-appointment interval. J Appl Behav Anal. 1984;17:295–301.PubMedCrossRef
Finnerty FA Jr, Mattie EC, Finnerty FA 3rd. Hypertension in the inner city. I. Analysis of clinic dropouts. Circulation. 1973;47:73–5.PubMed
Rosenblut A, Jonas S, Wassertheil S, et al. OPD waiting time reduced by use of an individual appointment system. Hosp Topics. 1972;49–53.
Oppenheim GL, Bergman JJ, English EC. Failed appointments: a review. J Fam Pract. 1979;8:789.PubMed
Hurtado AV, Greenlick MR, Colombo TJ. Determinants of medical care utilization: failure to keep appointments. Med Care. 1973;11:189–98.PubMedCrossRef
Kiefe C, Harrison P. Post-hospitalization followup appointment-keeping among the medically indigent. J. Community Health. 1993;18:271–82.PubMedCrossRef
Cohen SJ. New metaphors for old problems. In: Cohen SJ (ed). New Directions in Patient Compliance. Lexington, MA: Lexington Books, 1979;153–63.
Probstfield JL, Russell ML, Insull W, Yusuf S. Dropouts for a clinical trial, their recovery and characterization: a basis for dropout management and prevention. In: Health Behavior Change Handbook. New York: Springer, 1990;376–400.
Cramer JA, Collins JF, Mattson RH. Can categorization of patient background problems be used to determine early termination in a clinical trial? Controlled Clin Trials. 1988;9:47–63.PubMedCrossRef
Fletcher SW, Appel FA, Bourgois M. Improving emergency-room patient follow-up in a metropolitan teaching hospital. Effect of a follow-up clerk. N Engl J Med. 1974;291:385–8.PubMedCrossRef
Bigby JA, Giblin J, Pappius EM, Goldman L. Appointment reminders to reduce no-show rates-a stratified analysis of their cost-effectiveness. JAMA. 1983;250:1742–5.PubMedCrossRef
Grover S, Gagnon G, Flegel KM, Hoey JR. Improving appointment-keeping by patients new to a hospital medical clinic with telephone or mail reminders. Can Med Assoc J. 1983;129:1101–3.PubMed
Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA. 1992;267:1813–7.PubMedCrossRef
Schroeder SA. Lowering broken appointment rates at a medical clinic. Med Care. 1973;11:75–8.PubMedCrossRef
Morse DL, Coulter MP, Nazarian LF, et al. Waning effectiveness of mailed reminders on reducing broken appointments. Pediatrics. 1981;68:846–9.PubMed
Smith PB, Weinman ML, Johnson TC, Wait RB. Incentives and their influence on appointment compliance in a teenage family-planning clinic. J Adolesc Health Care. 1990;11:445–8.PubMedCrossRef
Reuss ML, Piotrowski WD, Bailey JS. Behavioral community psychology: encouraging low-income parents to seek dental care for their children. J Appl Behav Anal. 1976;9:387–97.CrossRef
Ossip-Klein DJ, Vanlandingham W, Prue DM, Rychtarik RG. Increasing attendance at alcohol aftercare using calendar prompts and home-based contracting. Addict Behav. 1984;9:85–9.PubMedCrossRef
Levy RL, Clark H. The use of an overt commitment to enhance compliance: a cautionary note. J Behav Ther Exp Psychiatry. 1980;11:105–7.CrossRef
Barry SP, Daniels AA. Effecting change in outpatient failed appointments. J Fam Pract. 1984;18:739–42.PubMed